The prevalence and clinical characteristics of T2-high and T2-low endotype of severe uncontrolled asthma distinguished by combining popular type-2 biomarkers
K. Oishi (Ube, Japan), T. Hirano (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), S. Uehara (Ube, Japan), R. Suetake (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), K. Matsunaga (Ube, Japan)
Source: International Congress 2019 – Clinical aspects of airway diseases
Session: Clinical aspects of airway diseases
Session type: Thematic Poster
Number: 2749
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Oishi (Ube, Japan), T. Hirano (Ube, Japan), K. Matsuda (Ube, Japan), K. Hamada (Ube, Japan), S. Uehara (Ube, Japan), R. Suetake (Ube, Japan), Y. Yamaji (Ube, Japan), M. Asami-Noyama (Ube, Japan), N. Edakuni (Ube, Japan), K. Matsunaga (Ube, Japan). The prevalence and clinical characteristics of T2-high and T2-low endotype of severe uncontrolled asthma distinguished by combining popular type-2 biomarkers. 2749
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003
BREATHE – Distribution and co-expression of T2 biomarkers in asthma and association with severity, clinical characteristics and co-morbidities Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
The subclinical atherosclerosis and its association to clinical features of stable COPD Source: Annual Congress 2011 - COPD management Year: 2011
Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021
Clinical characteristics of severe asthma subphenotypes Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012
Identification of treatable traits in a severe asthma registry: prevalence and exacerbation predictors Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Baseline characteristics of severe asthma patients initiating biologic treatment worldwide Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Age-of-asthma onset and epidemiological characteristics of late-onset asthma in a general population Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 257s Year: 2002
Relationship between longitudinal changes in type-2 inflammation and clinical outcomes in young asthmatics Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma Year: 2021
Defining the clinical clusters of severe asthma within UBIOPRED Source: International Congress 2015 – Fingerprinting severe asthma Year: 2015
Features of differences in clinical anamnestic, functional indicators, and alpha-1-antitripsin, in teenagers with chronic bronchitis, in the gender-age aspect Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Component-resolved allergy diagnostics identify phenotypes in problematic severe childhood asthma Source: Annual Congress 2011 - Risk and detection of childhood asthma and allergy Year: 2011
Clinical characteristics of adult obese asthma with type-2 inflammation dominant Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD Year: 2020
Prevalence and clinical relevance of comorbidities in IPF Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018